STOCK TITAN

Vanguard subsidiaries disaggregate holdings; GEHC shows 0 shares (GEHC)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

GE HealthCare Technologies Inc Schedule 13G/A amendment shows The Vanguard Group reporting 0 shares and 0% beneficial ownership of Common Stock as of the amendment. The filing notes an internal realignment on 01/12/2026 that led to disaggregated reporting by Vanguard subsidiaries.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports no beneficial ownership after internal disaggregation.

The amendment states 0 shares and 0% ownership, reflecting a reporting change following an internal realignment described in SEC Release No. 34-39538 on 01/12/2026. This is an administrative disclosure, not a market trade.

Cash‑flow treatment and trading intent are not stated in the excerpt; subsequent filings by Vanguard subsidiaries may show redistributed positions.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What does the GEHC Schedule 13G/A amendment disclose?

The filing discloses that The Vanguard Group reports beneficial ownership of 0 shares, equal to 0%. It explains the change results from an internal realignment and separate reporting by Vanguard subsidiaries per SEC guidance dated 01/12/2026.

Did Vanguard sell GE HealthCare (GEHC) shares according to this amendment?

The amendment does not state any sale or purchase; it reports 0 shares beneficially owned. The text attributes the change to internal reorganization and disaggregated reporting under SEC Release No. 34-39538, not to a specific trading transaction or proceeds.

When did Vanguard’s internal realignment occur as noted in the GEHC filing?

The filing cites an internal realignment on 01/12/2026 referenced to SEC Release No. 34-39538. That realignment prompted subsidiaries to report holdings separately; the amendment itself is signed on 03/26/2026.

Who signed the Schedule 13G/A amendment for GEHC?

The amendment is signed by Ashley Grim, identified as Head of Global Fund Administration. The signature block shows the signing date as 03/26/2026 and lists Vanguard’s Malvern, PA address.

Does this amendment change GEHC’s outstanding shares or investor percentages?

No company‑level share counts or changes to outstanding shares are provided. The amendment only reports Vanguard’s beneficial ownership as 0 shares (0%) after internal disaggregation; it does not state any change to GEHC’s total shares outstanding.
Ge Healthcare Technologies Inc

NASDAQ:GEHC

View GEHC Stock Overview

GEHC Rankings

GEHC Latest News

GEHC Latest SEC Filings

GEHC Stock Data

32.64B
454.35M
Medical Devices
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States
CHICAGO